Neuphoria Therapeutics Inc. (NEUP) stock
NEUPNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-K on Sep 18, 2026Score 5/30
$2.27−0.21 (-8.47%)
Close on Nov 17, 2026Market cap $68.24KP/E –Yield –
Neuphoria Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Neuphoria Therapeutics's pe ratio was 0.0× on Jul 31, 2025.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jul 31, 2025 | 0.0× | – |
See a number that looks wrong?